Michael Siluk/UCG/Universal Images Group via Getty Images
With weight-loss drugs like WeGovy and Ozempic dominating many of today's consumer healthcare conversations, there's a mounting concern for a particularly vulnerable group: children.
Michael Siluk/UCG/Universal Images Group via Getty Images
With weight-loss drugs like WeGovy and Ozempic dominating many of today's consumer healthcare conversations, there's a mounting concern for a particularly vulnerable group: children.
No comments